Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Covid-19 Associated Extreme Fatigue Effects on Activities of Daily Living in Mild and Long-Haul Infections: Patient Perspectives from a Remote Patient Monitoring Program
Infectious Disease
P3 - Poster Session 3 (5:30 PM-6:30 PM)
4-002

Extreme fatigue has been shown to be a neurological effect of COVID-19 infection. It is critical to better understand the impact this symptom has on daily functioning across the spectrum of morbidity associated with COVID-19 infection. Patient perspective on extreme fatigue affords deeper insight into illness experience, clinical course of COVID-19 associated fatigue, and opportunities for neurological and social intervention. 


Here, we report the impact of COVID-19 associated extreme fatigue on activities of daily living from the patient perspective in both mild and long haul COVID-19 patients. This narrative emphasis will offer opportunities for the development of neurological protocols and interventions for the treatment and support of affected individuals.
46 Patients in a COVID-19 Remote Patient Monitoring Program (Precision Recovery: Mount Sinai Health System) were interviewed regarding their experience with COVID-19. Patients were asked about their experiences navigating COVID-19 diagnoses, the health care system, and their recovery process. References to fatigue were analyzed for statistical and qualitative significance.

34/46 patients (74%) reported extreme fatigue as a symptom of their COVID-19 infection. 16/34 patients (47%) were self-reported long haul COVID-19 patients, which represented 16/18 (89%) of the long haul patients in the study. Patients reported three categories of impact on activities of daily living: (1) care for self; (2) care for others; and (3) employment responsibilities and continuation. The critical secondary effects of this fatigue included: (1) barrier to healthcare; (2) social isolation; (3) malnutrition; (4) necessity of outside caretakers for children; and (5) employment termination. 


COVID-19 extreme fatigue had debilitating effects on activities of daily living for both mild and long-haul patients. This is critical to acknowledge, not only for development of protocol and interventional treatment, but also for the development of social support for impacted individuals, including food access, child care, and employment response. 



Authors/Disclosures

PRESENTER
No disclosure on file
Emma Reford Ms. Reford has nothing to disclose.
Natalia Romano Spica Ms. Romano Spica has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
Christopher P. Kellner, MD (Mount Sinai Health System) Dr. Kellner has stock in METIS Innovative. Dr. Kellner has stock in Precision Recovery. Dr. Kellner has stock in Synchron. Dr. Kellner has stock in Fluid BioMed. Dr. Kellner has stock in Proprio. Dr. Kellner has stock in Von Vascular. Dr. Kellner has stock in E8. Dr. Kellner has stock in Borvo. Dr. Kellner has stock in Phantom Neuro. The institution of Dr. Kellner has received research support from Integra. The institution of Dr. Kellner has received research support from Penumbra. The institution of Dr. Kellner has received research support from Viz.AI. The institution of Dr. Kellner has received research support from ICE Neurosystems. The institution of Dr. Kellner has received research support from Irras. The institution of Dr. Kellner has received research support from Microtransponder. The institution of Dr. Kellner has received research support from Medtronic. The institution of Dr. Kellner has received research support from Longeviti. The institution of Dr. Kellner has received research support from Endostream. The institution of Dr. Kellner has received research support from CVAID.